SEC Comment Letter for BIOLIFE SOLUTIONS INC (BLFS) (CIK 0000834365) (BLFS) — Aug 4, 2005
BIOLIFE SOLUTIONS INC (BLFS) (CIK 0000834365)
Date: Aug. 4, 2005 · CIK: 0000834365 · Accession: 0000000000-05-040213
AI Filing Summary & Sentiment
Letter
August 4, 2005 Dr. John G. Baust, Chief Executive Officer and Chief Financial Officer BioLife Solutions, Inc. 171 Front Street Owego, New York 13827 Via U S Mail and FAX [ (607) 687-6683 ]
Re: BioLife Solutions, Inc. Form 10-K for the fiscal year ended December 31, 2004 Form 10-Q for the fiscal quarter ended March 31, 2005 File No. 0-18170
Dear Dr. Baust:
We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments.
Sincerely,
Martin F. James
Senior Assistant Chief
Accountant
Show Raw Text
<DOCUMENT> <TYPE>LETTER <SEQUENCE>1 <FILENAME>filename1.txt <TEXT> Mail Stop 6010 August 4, 2005 Dr. John G. Baust, Chief Executive Officer and Chief Financial Officer BioLife Solutions, Inc. 171 Front Street Owego, New York 13827 Via U S Mail and FAX [ (607) 687-6683 ] Re: BioLife Solutions, Inc. Form 10-K for the fiscal year ended December 31, 2004 Form 10-Q for the fiscal quarter ended March 31, 2005 File No. 0-18170 Dear Dr. Baust: We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments. Sincerely, Martin F. James Senior Assistant Chief Accountant ?? ?? ?? ?? </TEXT> </DOCUMENT>